Salbutamol (Asthavent, Asthavent Dp-caps, Asthavent Ecohaler, Duolin Respules, Duolin Hfa, Asthavent Respules, Cipla-salbutamol Respules)
Salbutamol
Cipla Medpro (Pty) Ltd
Registration
- Applicant
- Cipla Medpro (Pty) Ltd
- Registrations
- 8
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Asthavent EACH ACTUATION CONTAINS SALBUTAMOL 100 mcg | Not listed | 30011930/10.2.1/0119 | Cancelled | Not determined | None |
| Asthavent syrup EACH 5 ml SYRUP CONTAINS SALBUTAMOL SULPHATE EQUIVALENT TO 2 mg SALBUTAMOL | 2,0 mg/5 mLSyrup | 30020030/10.2.2/0200Approved 8 March 2023 | Registered | Not determined | PIPIL |
| Asthavent dp-caps EACH ROTACAP CONTAINS SALBUTAMOL SULPHATE EQUIVALENT TO 0,2 mg SALBUTAMOL | Not listed | 30034530/10.2.1/0345 | Cancelled | Not determined | None |
| Asthavent ecohaler EACH ACTUATION CONTAINS SALBUTAMOL SULPHATE EQUIVALENT TO SALBUTAMOL 100,0 ug | 100 µgMetered dose inhaler | 34035434/10.2.1/0354Approved 5 November 2025 | Registered | S2 | PIPIL |
| Duolin respules EACH 2,5 ml SOLUTION CONTAINS IPRATROPIUM BROMIDE EQUIVALENT TO IPRATROPIUM 0,5 mg SALBUTAMOL SULPHATE EQUIVALENT TO SALBUTAMOL 2,5 mg | 0,5 mg/2,5 mg in 2,5 mLSolution. | 37001237/10.2.1/0012Approved 6 March 2026 | Registered | S3 | PIPIL |
| Duolin hfa inhaler EACH METERED DOSE CONTAINS IPRATROPIUM BROMIDE EQUIVALENT TO IPRATROPIUM 20,0 ug SALBUTAMOL SULPHATE EQUIVALENT TO SALBUTAMOL 100,0 ug | Inhaler | 41090841/10.2.1/0908 | Registered | Not determined | None |
| Asthavent respules EACH 2,5 ml SOLUTION CONTAINS SALBUTAMOL SULPHATE EQUIVALENT TO SALBUTAMOL 2,5 mg | Not listed | A390482A39/10.2.1/0482 | Cancelled | Not determined | None |
| Cipla-salbutamol respules EACH 2,5 ml SOLUTION CONTAINS SALBUTAMOL SULPHATE EQUIVALENT TO SALBUTAMOL 2,5 mg | Not listed | A390483A39/10.2.1/0483 | Cancelled | Not determined | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, read from the product's PI-PIL leaflet.
The Consolidated Schedules list this ingredient up to S4; the leaflet's S3 applies to this product.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Ipratropium bromide equivalent to ipratropium, salbutamol sulphate equivalent to salbutamol
S4: Salbutamol
- when intended for injection.
Consolidated Schedules 06 July 2026, line 7867
S3: Ipratropium
- when contained in respirator solutions.
Consolidated Schedules 06 July 2026, line 3804
S3: Salbutamol
- when contained in respirator solutions.
Consolidated Schedules 06 July 2026, line 4238
S2: Ipratropium
- except when contained in respirator solutions.
Consolidated Schedules 06 July 2026, line 2177
S2: Salbutamol
- when contained in respirator solutions; (S3) and
- when intended for injection. (S4)
Consolidated Schedules 06 July 2026, lines 2654 to 2658
Pharmacological class: inhalants. (class 10.2.1)
Matched through the component Ipratropium.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol
Drag to rotate. Structure from PubChem CID 2083.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.